DMSc, Hans Christian Andersen Children's Hospital, Sdr Boulevard 29, DK-5000 Odense C, Denmark.
Pediatrics. 2010 Mar;125(3):e518-24. doi: 10.1542/peds.2009-0375. Epub 2010 Feb 1.
Antibody screenings and diagnosis of celiac disease (CD) among children with type 1 diabetes have suggested that a considerable proportion of children with CD may, in fact, have preclinical (undiagnosed) symptoms. We aimed to test if a questionnaire would lead to significant case finding in an unselected population of 8- to 9-year-old children.
The study population included 9880 children aged 8 to 9 years. Before the study, 13 children from the study population were known to have CD. We developed a questionnaire on the basis of 5 simple items suggestive of CD and mailed the questionnaire to the families of all children in the study population who resided in the County of Funen, Denmark. In total, 7029 respondents returned the questionnaire (70%); among them, 2835 children had 1 or more symptoms. These children were invited for a blood test to determine their human serum immunoglobulin A (IgA) anti-tissue transglutaminase antibody (anti-tTG) levels.
Of the 1720 children who were tested for the human serum IgA anti-tTG, 24 participants had a positive result (range: 20 to >150 U). Seventeen of these children underwent an upper endoscopy procedure. Fourteen children had histologic signs of CD (Marsh classification stage III). Fourteen children met the diagnostic criteria for CD. The prevalence proportion of patients who were newly diagnosed with CD was 0.14% (95% CI: 0.08-0.24) (14 of 9967), and the estimate of the minimum total prevalence proportion of children with CD was 0.27% (95% CI: 0.18-0.39) (27 of 9980). The maximal prevalence proportion of patients with newly diagnosed CD was 1.22% (95% CI: 0.76-1.90) (21 of 1720), including those participants who had a positive anti-tTG result but not a final diagnosis of CD. The ratio of known to minimally symptomatic CD was approximately 1:1.
A number of preclinical and low-grade symptomatic patients with CD may be identified by their responses to a mailed questionnaire.
在 1 型糖尿病患儿中进行抗体筛查和乳糜泻(CD)诊断表明,相当一部分 CD 患儿实际上可能存在临床前(未确诊)症状。我们旨在测试问卷是否会在未选择的 8 至 9 岁儿童人群中发现显著病例。
研究人群包括 9880 名 8 至 9 岁的儿童。在研究之前,研究人群中有 13 名儿童已知患有 CD。我们基于 5 个提示 CD 的简单项目制定了一份问卷,并将问卷邮寄给居住在丹麦菲英郡的研究人群中所有儿童的家庭。共有 7029 名应答者(70%)返回了问卷;其中,2835 名儿童有 1 个或多个症状。这些儿童被邀请进行血液检查以确定其人血清免疫球蛋白 A(IgA)抗组织转谷氨酰胺酶抗体(抗 tTG)水平。
在接受人血清 IgA 抗 tTG 检测的 1720 名儿童中,24 名儿童的结果呈阳性(范围:20 至> 150 U)。其中 17 名儿童进行了上内窥镜检查。14 名儿童有 CD 的组织学征象(Marsh 分类阶段 III)。14 名儿童符合 CD 的诊断标准。新诊断为 CD 的患者患病率为 0.14%(95%CI:0.08-0.24)(9967 名中的 14 名),估计 CD 患儿的最低总患病率为 0.27%(95%CI:0.18-0.39)(9980 名中的 27 名)。新诊断为 CD 的患者患病率最高为 1.22%(95%CI:0.76-1.90)(1720 名中的 21 名),包括那些抗 tTG 结果阳性但最终未诊断为 CD 的参与者。已知有症状和无症状 CD 的患者比例约为 1:1。
通过邮寄问卷,可能会发现一些临床前和低级别症状的 CD 患者。